Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease

[1]  E. Hirsch,et al.  Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in parkinson's disease and rat with 6‐OHDA lesion , 1996, The Journal of comparative neurology.

[2]  Y. Agid,et al.  Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes , 1996, Neurology.

[3]  C. Weickert,et al.  GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice , 1995, Neurobiology of Aging.

[4]  E. Hirsch,et al.  Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson's disease , 1995, Neuroscience Letters.

[5]  B. Bloch,et al.  Ontogeny of the striatal neurons expressing neuropeptide genes in the human fetus and neonate , 1995, The Journal of comparative neurology.

[6]  C. Feuerstein,et al.  GDNF: existence of a second transcript in the brain. , 1995, Brain research. Molecular brain research.

[7]  E. Mufson,et al.  Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  Y. Agid,et al.  Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA , 1995, The European journal of neuroscience.

[9]  A. Granholm,et al.  Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons , 1995, The Journal of comparative neurology.

[10]  Y. Ben-Ari,et al.  Cell death, gliosis, and synaptic remodeling in the hippocampus of epileptic rats. , 1995, Journal of neurobiology.

[11]  K. Unsicker,et al.  TGF‐beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. , 1995, The EMBO journal.

[12]  C. Spenger,et al.  Comparison of the Effects of the Neurotrophins on the Morphological Structure of Dopaminergic Neurons in Cultures of Rat Substantia Nigra , 1995, The European journal of neuroscience.

[13]  L. Bergman,et al.  cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle , 1995, Experimental Neurology.

[14]  L. Olson,et al.  Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo , 1995, Nature.

[15]  R. Vandlen,et al.  Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain , 1995, Nature.

[16]  K. Unsicker,et al.  GDNF is expressed in two forms in many tissues outside the CNS. , 1994, Neuroreport.

[17]  H. Phillips,et al.  TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons , 1994, Neuron.

[18]  L. Olson,et al.  Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. , 1994, Brain research. Molecular brain research.

[19]  S. Wiegand,et al.  Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine Lesions , 1994, Journal of neurochemistry.

[20]  J. Trojanowski,et al.  Expression of GDNF mRNA in Rat and Human Nervous Tissue , 1994, Experimental Neurology.

[21]  E. Jones,et al.  Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease , 1994, Neuroscience.

[22]  L. Olson,et al.  Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger rna in response to kainate-induced excitation , 1994, Neuroscience.

[23]  Rhonda,et al.  Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  I. Black,et al.  Regional and Cell-Specific Expression of GDNF in Rat Brain , 1993, Experimental Neurology.

[25]  L. Olson,et al.  Glial Cell Line-Derived Neurotrophic Factor Is Expressed in the Developing but Not Adult Striatum and Stimulates Developing Dopamine Neurons in Vivo , 1993, Experimental Neurology.

[26]  J. Fawcett,et al.  Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons—i. Effectsin vitro , 1993, Neuroscience.

[27]  J. Fawcett,et al.  Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons—II. Effects on nigral transplantsin vivo , 1993, Neuroscience.

[28]  F. Hefti,et al.  Trophic actions of transforming growth factor α on mesencephalic dopaminergic neurons developing in culture , 1993, Neuroscience.

[29]  S. Varon,et al.  Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[31]  K. Unsicker,et al.  FGF‐2‐mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: Specificity and impact of culture conditions, non‐dopaminergic neurons, and astroglial cells , 1993, Journal of neuroscience research.

[32]  F. Hefti,et al.  The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth FACTOR-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture , 1993, Neuroscience.

[33]  E. Hirsch,et al.  Glutathione peroxidase, glial cells and Parkinson's disease , 1993, Neuroscience.

[34]  Richard S. J. Frackowiak,et al.  Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.

[35]  Steven A. Johnson,et al.  BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease , 1991, Neuron.

[36]  N. Neff,et al.  Epidermal Growth Factor Enhances Striatal Dopaminergic Parameters in the 1‐Methyl‐4‐Phenyl‐l, 2, 3, 6‐Tetrahydropyridine‐Treated Mouse , 1991, Journal of neurochemistry.

[37]  K. Unsicker,et al.  Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  J. Schwaber,et al.  Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[40]  E. Hirsch,et al.  Is dopaminergic cell death accompanied by concomitant nerve plasticity? , 1996, Advances in neurology.

[41]  K. Unsicker.  Growth factors in Parkinson's disease. , 1994, Progress in growth factor research.

[42]  Y Agid,et al.  Are dopaminergic neurons selectively vulnerable to Parkinson's disease? , 1993, Advances in neurology.